ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Trends in Grade 5 Toxicity and Response in Phase I Trials in Hematologic Malignancy: 20-Year Experience From the Cancer Therapy Evaluation Program at the National Cancer Institute.

Dai Chihara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.